Despite the wide range of proposed uses for BV and melittin,
the pharmacological effects in the central nervous system
that result from their administration under physiological
conditions have been poorly addressed. The development
of new therapeutic approaches to mental disorders and
neurodegenerative diseases remains a challenge. So, this
study aimed to examine the pharmacological effects of BV and
melittin in mice, with particular emphasis on dopaminergic
related behaviors.